| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.730 | 19.364 | 16.887 | 25.562 | 25.406 | 48.080 | 32.551 | 20.413 | 29.211 | 135.005 |
| Total Income - EUR | 34.730 | 19.364 | 16.887 | 25.562 | 25.406 | 48.119 | 32.552 | 20.417 | 29.212 | 135.197 |
| Total Expenses - EUR | 22.965 | 11.975 | 17.518 | 24.098 | 21.217 | 45.175 | 32.613 | 28.163 | 41.056 | 109.094 |
| Gross Profit/Loss - EUR | 11.764 | 7.390 | -632 | 1.464 | 4.189 | 2.943 | -61 | -7.747 | -11.844 | 26.103 |
| Net Profit/Loss - EUR | 10.722 | 6.809 | -1.138 | 697 | 3.426 | 1.500 | -992 | -8.131 | -12.136 | 23.028 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Mymed Consumabile S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.797 | 1.713 | 1.625 | 1.532 | 1.440 | 1.352 | 2.062 | 2.557 | 12.395 | 10.049 |
| Current Assets | 17.114 | 7.167 | 13.548 | 9.318 | 11.580 | 32.072 | 37.412 | 12.880 | 10.153 | 20.248 |
| Inventories | 5.370 | 0 | 0 | 0 | 0 | 4.394 | 0 | 0 | 0 | 9.962 |
| Receivables | 338 | 1.017 | 1.616 | 569 | 2.127 | 25.407 | 13.729 | 8.966 | 4.325 | 7.852 |
| Cash | 11.407 | 6.151 | 11.932 | 8.750 | 9.454 | 2.271 | 23.683 | 3.914 | 5.828 | 2.434 |
| Shareholders Funds | 17.403 | 7.663 | 6.395 | 6.975 | 10.267 | 6.198 | 5.069 | -6.248 | -18.365 | 4.765 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.508 | 1.218 | 8.778 | 3.875 | 2.754 | 27.226 | 34.405 | 21.685 | 40.913 | 25.532 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Mymed Consumabile S.r.l.